Invited Seminars Held in 2002

Invited Seminars Held in 2002

Jan 21

Jorma Ahokas (Professor, Toxicology, School of Medical Sciences, RMIT-University, Australia)
Dietary aflatoxins -Can their bioavailability be reduced?
Organized by Cancer Prevention Division

Jan 22

Yvonne P Dragan (Director, Laboratory of Hepatotoxicity, National Institute of Toxicological Research, USA)
Transgenic rat models of carcinogenesis
Organized by Experimental Pathology and Chemotherapy Division

Jan 23

Jerrold M Ward (Chief, Laboratory of Experimental Animal Pathology, NCI-FCRDC, USA)
Pathology of preneoplasia- from animal to human-classification and molecular pathology of preneoplastic and precancerous lesions in rodents
Organized by Experimental Pathology and Chemotherapy Division

Paul H Duray (Senior Staff, Laboratory of Pathology Center for Cancer Research, NCI, USA)
Pathology of preneoplasia- from animal to human-molecular pathology of preneoplasia: a topic for knockout/in mice models
Organized by Experimental Pathology and Chemotherapy Division

Peter A Jones (Director, University of South California, Norris Comprehensive Cancer Center, USA)
DNA methylation and chromatin structural changes in tumor suppressor genes and their reversal with a novel inhibitor
Organized by DNA Methylation and Genome Function Project

Yusuke Nakamura (Professor, Director, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Japan)
Identification of target genes of p53 and functional analysis of the gene products
Organized by Cancer Genomics Division

Jan 25

Takashi Tsuruo (Director, Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan)
Molecular target therapy: Recent advance and approach from basic research
Organized by Director’s Office

Feb 12

Yoshihiro Nakatani (Professor, Harvard Medical School Dana-Farber Cancer Institute, USA)
New functions of RB and E2F
Organized by Radiobiology Division

Feb 22

Parry Guilford (Principal Investigator, Cancer Genetics Laboratory, University of Otago, New Zealand)
E-cadherin germline mutations in familial gastric cancer
Organized by Carcinogenesis Division

Mar 6

Tsukasa Sasaki (Associate Professor, Health Service Center, University of Tokyo, Japan)
Methodological difficulty and strategy to identify gene related to psychiatric disorders and personality trait
Organized by Psycho-Oncology Division

Yoshiyuki Sakaki (Professor, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Japan)
Comparative genomics for decoding our genome
Organized by Cancer Genomics Division

Mar 25

Bandaru S Reddy (Associate Director of Research, Chief, Division of Nutritional Carcinogenesis, American Health Foundation, USA)
Novel approaches for chemoprevension of colon cancer by combination of selective agents with different modes of action
Organized by Cancer Prevention Division

Apr 2

Toshio Kitamura (Professor, Division of Cellular Therapy Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan)
Usefulness of retro-virus vectors in various research fields
Organized by Biochemistry Division

Apr 19

Masanori Hatakeyama (Proffesor, Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University, Japan)
Molecular target of Helicobacter pylori and molecular mechanism for gastric carcinogenesis
Organized by Biochemistry Division

Shoji Ueda (Director, YS New Technology Laboratory, Japan)
Current status of transgenic technology in the rat
Organized by Carcinogenesis Division

May 14

Scott C Goodwin (Chief and Chairman, Department of Radiology, Wayne State University / Detroit Medical Center, USA)
Magnetic targeted drug delivery: An overview
Organized by Section for Studies on Metastasis

May 24

Kiyoshi Miyagawa (Professor, Department of Molecular Pathology, Division of Genome Bilogy, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan)
Homologous recombinations in human somatic cells
Organized by Biochemistry Division

Masami Watanabe (Professor, Division of Radiation Biology, Department of Radiology and Radiation Biology, Graduate school of Biomedical Sciences, Nagasaki University, Japan)
Molecular mechanism underlying the induction of radiation-induced late-onset genetical instability
Organized by Biochemistry Division

Shigeo Ohno (Professor, Department of Biochemistry, Yokohama City University, School of Medicine, Japan)
Epithelial cell polarity and PAR-aPKCcomplex
Organized by Director’s Office

May 31

Hiroshi Ohshima (Chief, Unit of Endogenous Cancer Risk Factors, International Agency for Research on Cancer, France)
Modification of DNA and protein by inflammation reaction products: its application to molecular cancer epidemiology
Organized by Cancer Prevention Division

Jun 25

Tetsuhiko Shirasaka (Director, TAIHO Pharmaceutical Co., Ltd., Laboratory of Pathogenic Biochemistory in Medicine, Japan)
News strategy of cancer chemotherapy: biochemical modulation of 5-FU
Organized by Director’s Office of Research Institute East

Jul 8

Eiji Hara (Group Leader, Cell Cycle Group, Paterson Institute for Cancer Research, United Kingdom)
Regulation of p16INK4a expression and cancer
Organized by Radiobiology Division

Jul 23

Masataka Okabe (Assistant Professor, Division of Developmental Genetics, National Institute of Genetics Department of Genetics, Graduate University for advanced Studies, Japan)
How to make figures and presentations that are friendly to color blind people
Organized by Psycho-Oncology Division

Masataka Okabe (Assistant Professor, Division of Developmental Genetics, National Institute of Genetics Department of Genetics, Graduate University for advanced Studies, Japan)
The molecular mechanism of sensory organ specification in the fruit fly development
Organized by Psycho-Oncology Division

Jul 24

Chung-Cheng Hsieh (Professor, Division of Biostatistics and Epidemiology, Cancer Center, University of Massachusetts Medical School, USA)
Dual effect of childbirth on maternal breast cancer risk stem cells and perinatal factor for breast cancer
Organized by Epidemiology and Biostatistics Division

Jan-Ake Gustafsson (Professor, Chairman, Department of Medical Nutrition, Karolinska Institute, Sweden)
Novel aspects on estrogen signaling and hormone dependent cancer
Organized by Cancer Prevention Division

Aug 19

Walter F Baile (Chief of Psychiatry Section, Professor of Psychiatry, University of Texas MD Anderson Cancer Center, USA)
Applying the spikes protocol to end of life discussions
Organized by Psycho-Oncology Division

Aug 21

Akeo Shinkai (Research Staff, Tokyo Research Laboratories, Kyowa Hakko Kogyo Co, Ltd, Japan)
Mutator mutants of E.coli DNA polymerase I
Organized by Biochemistry Division

Aug 23

Walter F Baile (Chief of Psychiatry Section, Professor of Psychiatry, University of Texas MD Anderson Cancer Center, USA)
Evaluating the effectiveness of workshops
Organized by Psycho-Oncology Division

Sep 14

Jimmie C Holland (Chairperson, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, USA)
Improving the human side of cancer care; Psycho-oncology’s contribution
Organized by Psycho-Oncology Division

Sep 16

Jimmie C Holland (Chairperson, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, USA)
Distress; A universal response to cancer
Organized by Psycho-Oncology Division

Sep 20

Kiyoto Kasai (Instructor, Department of Neuropsychiatry, Graduate School of Medicine, University of Tokyo, Japan)
New findings of neuroimaging study in schizophrenia
Organized by Psycho-Oncology Division

Sep 27

Toshiaki Furukawa (Professor, Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University, Graduate School of Medical Sciences, Japan)
The practice of evidence based medicine
Organized by Psycho-Oncology Division

Oct 4

Wei Gu (Assistant Professor, Institute of Cancer Genetics and Department of Pathology, College of Physicians & Surgeons, Columbia University, USA)
Regulation of p53 stability by deubiquitination and acetylation
Organized by Radiobiology Division

Yoshitaka Tsubono (Associate Professor, Department of Public Health & Forensic Medicine, Tohoku University, Graduate School of Medicine, Japan)
Prospective cohort-study on personality and cancer morbidity
Organized by Psycho-Oncology Division

Nov 1

Etsuro Mori (Section Head, Institute for Aging Brain and Congnitive Disorders, Hyogo Brain and Heart Center, Japan)
Neuropsychological approach to behavioral and congnitive disoders
Organized by Psycho-Oncology Division

Nov 2

Zeev Ronai (Professor, Ruttenberg Cancer Center, Mount Sinai School of Medicine, USA)
RNF5-novel ring finger protein and its effects on paxillin localization and cell motility
Organized by Biochemistry Division

Nov 8

Takeshi Inoue (Assistant Professor, Department of Psychiatry, Hokkaido University, School of Medicine, Japan)
Conditioned fear stress and serotonin function
Organized by Psycho-Oncology Division

Nov 11

John E French (Group Leader, Transgenic Carcinogenesis, Laboratory of Molecular Toxicology, Division of Intramural Research, National Institute of Environmental Health Sciences, USA)
p53 Haploinsufficiency, loss of heterozygosity, and tumorigenesis
Organized by Experimental Pathology and Chemotherapy Division

Nov 15

James K Selkirk (Deputy Director, National Center for Toxicogenomics, National Institute of Environmental Health Sciences, USA)
Current research efforts at the U.S. National Center for Toxicogenomics
Organized by Cancer Prevention Basic Research Project

Nov 22

Hiroaki Kiyokawa (Assistant Professor, University of Illinois College of Medicine, Department of Molecular Genetics, USA)
Regulation of immortalization and transformation by G1-cyclin/Cdk
Organized by Radiobiology Division

Nov 25

Dave S B Hoon (Director, Department of Molecular Oncology, John Wayne Institute for Cancer Treatment and Research, USA)
New approaches for vaccine immunotherapy and molecular diagnosis of malignant melanoma
Organized by Section for Studies on Metastasis

Dec 9

David B West (Senior Director, Preclinical Development, Xenogen Corporation, USA)
Bradley W Ricet (Director, Physics R&D, Xenogen Corporation, USA)
In vivo biophotonic imaging and the xenogen IVIS imaging system
Organized by Section for Studies on Metastasis

Dec 20

Kenichi Nishioka (Postdoctoral Fellow, Howard Hughes Medical Institute, University of Medicine and Dentistry of New Jersey, USA)
The identification and analysis of the enzyme PR-Set7 that specifically modulates lysine 20 of histone H4
Organized by DNA Methylation and Genome Function Project


	Invited Seminars Held in 2002
	Jan 21 Jorma Ahokas (Professor, Toxicology, School of Medical Sciences, RMIT-University, Australia) Dietary aflatoxins -Can their bioavailability be reduced? Organized by Cancer Prevention Division Jan 22 Yvonne P Dragan (Director, Laboratory of Hepatotoxicity, National Institute of Toxicological Research, USA) Transgenic rat models of carcinogenesis Organized by Experimental Pathology and Chemotherapy Division Jan 23 Jerrold M Ward (Chief, Laboratory of Experimental Animal Pathology, NCI-FCRDC, USA) Pathology of preneoplasia- from animal to human-classification and molecular pathology of preneoplastic and precancerous lesions in rodents Organized by Experimental Pathology and Chemotherapy Division Paul H Duray (Senior Staff, Laboratory of Pathology Center for Cancer Research, NCI, USA) Pathology of preneoplasia- from animal to human-molecular pathology of preneoplasia: a topic for knockout/in mice models Organized by Experimental Pathology and Chemotherapy Division Peter A Jones (Director, University of South California, Norris Comprehensive Cancer Center, USA) DNA methylation and chromatin structural changes in tumor suppressor genes and their reversal with a novel inhibitor Organized by DNA Methylation and Genome Function Project Yusuke Nakamura (Professor, Director, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Japan) Identification of target genes of p53 and functional analysis of the gene products Organized by Cancer Genomics Division Jan 25 Takashi Tsuruo (Director, Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan) Molecular target therapy: Recent advance and approach from basic research Organized by Director’s Office Feb 12 Yoshihiro Nakatani (Professor, Harvard Medical School Dana-Farber Cancer Institute, USA) New functions of RB and E2F Organized by Radiobiology Division Feb 22 Parry Guilford (Principal Investigator, Cancer Genetics Laboratory, University of Otago, New Zealand) E-cadherin germline mutations in familial gastric cancer Organized by Carcinogenesis Division Mar 6 Tsukasa Sasaki (Associate Professor, Health Service Center, University of Tokyo, Japan) Methodological difficulty and strategy to identify gene related to psychiatric disorders and personality trait Organized by Psycho-Oncology Division Yoshiyuki Sakaki (Professor, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Japan) Comparative genomics for decoding our genome Organized by Cancer Genomics Division Mar 25 Bandaru S Reddy (Associate Director of Research, Chief, Division of Nutritional Carcinogenesis, American Health Foundation, USA) Novel approaches for chemoprevension of colon cancer by combination of selective agents with different modes of action Organized by Cancer Prevention Division Apr 2 Toshio Kitamura (Professor, Division of Cellular Therapy Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan) Usefulness of retro-virus vectors in various research fields Organized by Biochemistry Division Apr 19 Masanori Hatakeyama (Proffesor, Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University, Japan) Molecular target of Helicobacter pylori and molecular mechanism for gastric carcinogenesis Organized by Biochemistry Division Shoji Ueda (Director, YS New Technology Laboratory, Japan) Current status of transgenic technology in the rat Organized by Carcinogenesis Division May 14 Scott C Goodwin (Chief and Chairman, Department of Radiology, Wayne State University / Detroit Medical Center, USA) Magnetic targeted drug delivery: An overview Organized by Section for Studies on Metastasis May 24 Kiyoshi Miyagawa (Professor, Department of Molecular Pathology, Division of Genome Bilogy, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan) Homologous recombinations in human somatic cells Organized by Biochemistry Division Masami Watanabe (Professor, Division of Radiation Biology, Department of Radiology and Radiation Biology, Graduate school of Biomedical Sciences, Nagasaki University, Japan) Molecular mechanism underlying the induction of radiation-induced late-onset genetical instability Organized by Biochemistry Division Shigeo Ohno (Professor, Department of Biochemistry, Yokohama City University, School of Medicine, Japan) Epithelial cell polarity and PAR-aPKCcomplex Organized by Director’s Office May 31 Hiroshi Ohshima (Chief, Unit of Endogenous Cancer Risk Factors, International Agency for Research on Cancer, France) Modification of DNA and protein by inflammation reaction products: its application to molecular cancer epidemiology Organized by Cancer Prevention Division Jun 25 Tetsuhiko Shirasaka (Director, TAIHO Pharmaceutical Co., Ltd., Laboratory of Pathogenic Biochemistory in Medicine, Japan) News strategy of cancer chemotherapy: biochemical modulation of 5-FU Organized by Director’s Office of Research Institute East Jul 8 Eiji Hara (Group Leader, Cell Cycle Group, Paterson Institute for Cancer Research, United Kingdom) Regulation of p16INK4a expression and cancer Organized by Radiobiology Division Jul 23 Masataka Okabe (Assistant Professor, Division of Developmental Genetics, National Institute of Genetics Department of Genetics, Graduate University for advanced Studies, Japan) How to make figures and presentations that are friendly to color blind people Organized by Psycho-Oncology Division Masataka Okabe (Assistant Professor, Division of Developmental Genetics, National Institute of Genetics Department of Genetics, Graduate University for advanced Studies, Japan) The molecular mechanism of sensory organ specification in the fruit fly development Organized by Psycho-Oncology Division Jul 24 Chung-Cheng Hsieh (Professor, Division of Biostatistics and Epidemiology, Cancer Center, University of Massachusetts Medical School, USA) Dual effect of childbirth on maternal breast cancer risk stem cells and perinatal factor for breast cancer Organized by Epidemiology and Biostatistics Division Jan-Ake Gustafsson (Professor, Chairman, Department of Medical Nutrition, Karolinska Institute, Sweden) Novel aspects on estrogen signaling and hormone dependent cancer Organized by Cancer Prevention Division Aug 19 Walter F Baile (Chief of Psychiatry Section, Professor of Psychiatry, University of Texas MD Anderson Cancer Center, USA) Applying the spikes protocol to end of life discussions Organized by Psycho-Oncology Division Aug 21 Akeo Shinkai (Research Staff, Tokyo Research Laboratories, Kyowa Hakko Kogyo Co, Ltd, Japan) Mutator mutants of E.coli DNA polymerase I Organized by Biochemistry Division Aug 23 Walter F Baile (Chief of Psychiatry Section, Professor of Psychiatry, University of Texas MD Anderson Cancer Center, USA) Evaluating the effectiveness of workshops Organized by Psycho-Oncology Division Sep 14 Jimmie C Holland (Chairperson, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, USA) Improving the human side of cancer care; Psycho-oncology’s contribution Organized by Psycho-Oncology Division Sep 16 Jimmie C Holland (Chairperson, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, USA) Distress; A universal response to cancer Organized by Psycho-Oncology Division Sep 20 Kiyoto Kasai (Instructor, Department of Neuropsychiatry, Graduate School of Medicine, University of Tokyo, Japan) New findings of neuroimaging study in schizophrenia Organized by Psycho-Oncology Division Sep 27 Toshiaki Furukawa (Professor, Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University, Graduate School of Medical Sciences, Japan) The practice of evidence based medicine Organized by Psycho-Oncology Division Oct 4 Wei Gu (Assistant Professor, Institute of Cancer Genetics and Department of Pathology, College of Physicians & Surgeons, Columbia University, USA) Regulation of p53 stability by deubiquitination and acetylation Organized by Radiobiology Division Yoshitaka Tsubono (Associate Professor, Department of Public Health & Forensic Medicine, Tohoku University, Graduate School of Medicine, Japan) Prospective cohort-study on personality and cancer morbidity Organized by Psycho-Oncology Division Nov 1 Etsuro Mori (Section Head, Institute for Aging Brain and Congnitive Disorders, Hyogo Brain and Heart Center, Japan) Neuropsychological approach to behavioral and congnitive disoders Organized by Psycho-Oncology Division Nov 2 Zeev Ronai (Professor, Ruttenberg Cancer Center, Mount Sinai School of Medicine, USA) RNF5-novel ring finger protein and its effects on paxillin localization and cell motility Organized by Biochemistry Division Nov 8 Takeshi Inoue (Assistant Professor, Department of Psychiatry, Hokkaido University, School of Medicine, Japan) Conditioned fear stress and serotonin function Organized by Psycho-Oncology Division Nov 11 John E French (Group Leader, Transgenic Carcinogenesis, Laboratory of Molecular Toxicology, Division of Intramural Research, National Institute of Environmental Health Sciences, USA) p53 Haploinsufficiency, loss of heterozygosity, and tumorigenesis Organized by Experimental Pathology and Chemotherapy Division Nov 15 James K Selkirk (Deputy Director, National Center for Toxicogenomics, National Institute of Environmental Health Sciences, USA) Current research efforts at the U.S. National Center for Toxicogenomics Organized by Cancer Prevention Basic Research Project Nov 22 Hiroaki Kiyokawa (Assistant Professor, University of Illinois College of Medicine, Department of Molecular Genetics, USA) Regulation of immortalization and transformation by G1-cyclin/Cdk Organized by Radiobiology Division Nov 25 Dave S B Hoon (Director, Department of Molecular Oncology, John Wayne Institute for Cancer Treatment and Research, USA) New approaches for vaccine immunotherapy and molecular diagnosis of malignant melanoma Organized by Section for Studies on Metastasis Dec 9 David B West (Senior Director, Preclinical Development, Xenogen Corporation, USA) Bradley W Ricet (Director, Physics R&D, Xenogen Corporation, USA) In vivo biophotonic imaging and the xenogen IVIS imaging system Organized by Section for Studies on Metastasis Dec 20 Kenichi Nishioka (Postdoctoral Fellow, Howard Hughes Medical Institute, University of Medicine and Dentistry of New Jersey, USA) The identification and analysis of the enzyme PR-Set7 that specifically modulates lysine 20 of histone H4 Organized by DNA Methylation and Genome Function Project